Back Issue


reports and analyses of the forces driving
science and technology investment in Canada

copyright 1999, Research Money Inc.

editor: Mark Henderson


Volume 12, Number 15, SEPTEMBER 29, 1999

How it looks to me.... by Mark Henderson

FEATURE REPORTS | RESEARCH BRIEFS | PERSONALITIES

 

How it looks to me....


by Mark Henderson, editor, RE$EARCH MONEY The last time RE$EARCH MONEY wrote about the push to boost the capacity of government laboratories, we were told that its backers were still assessing which would be the best 'wagon' to hitch the initiative to (R$, April 28/99). Five months later, and on the eve of the throne speech, organizers still aren't saying much. But it's getting a lot easier to guess.

Of the S&T initiatives best placed to secure funding in the next Budget, two stand out as serving the needs of those who contend that increased science capacity is long overdue. Genome Canada and the Canadian Institutes of Health Research -- both profiled in the last issue of RE$EARCH MONEY -- are excellent examples of the kind of cross-cutting, multidisciplinary programs best suited to the new model emerging for government science. More generically, there are rumblings of more money for biotechnology, although the nasty food fight that's broken out in recent days may have a negative influence (link to item).

Put another way, government is likely to respond to the campaign by funding a wide variety of science-based initiatives, to shore up areas of obvious federal responsibility with an emphasis on collaboration. And although science capacity boosters are loathe to admit it, it's ultimately about money, and a lot of it. Government should be prepared to reverse the cuts of the past and heal the wounds that ill-advised cost cutting have inflicted.


Return to TOP OF PAGE | RE$EARCH MONEY INDEX



 

FEATURE REPORTS...


  SUCCESSFUL PUSH FOR INCREASED SCIENCE
CAPACITY WILL TRIGGER SEVERAL INITIATIVES
  AGBIOTECH IS FOCUS OF ESCALATING DEBATE AS BOTH SIDES GEAR UP FOR ULTIMATE SHOWDOWN DURING SEATTLE TRADE TALKS
  BLUE CHIP MEMBERS SELECTED FOR NEW BIOTECHNOLOGY ADVISORY COMMITTEE AS FEDERAL STRATEGY TAKES SHAPE
  CONFERENCE BOARD OF CANADA WEIGHS IN WITH REPORT
ON UNIVERSITY-INDUSTRY RESEARCH COLLABORATION
  JAPANESE TRADE MISSION GENERATES TECH DEALS
  BIOVAIL RAISING US$325 MILLION TO
FUND RAPID GROWTH AND ACQUISITIONS

Return to TOP OF PAGE | RE$EARCH MONEY INDEX



 

RESEARCH BRIEFS


  • CANARIE launches learning program to enhance education
  • Working Ventures teams with Univ of Waterloo to create fund
  • Ontario dominates ranking of 50 fastest growing Canadian firms
  • CME Telemetrix makes significant changes in corporate direction
  • UBC targets high school students with unique science program
  • Allelix's merger with NPS ends bid for new corporate partner
  • AxiaNet Media collaborates with Mayo Clinic on new web service
  • ImmGenics to develop monoclonal antibody with Genzyme Corp
  • Cangene R&D revenue jumps from Apotex project funding
  • Labopharm terminates longstanding deal with unnamed drug firm




Return to TOP OF PAGE | RE$EARCH MONEY INDEX






 

CANARIE launches learning program to enhance education CANARIE Inc has unveiled a new $25-million, four-year fund to encourage projects that reduce the structural impediments to the effective use of advanced networks from education and training. The Learning Program is a cost-shared fund designed to help finance demonstration projects, research test beds, repositories for learning objects and other innovations that will have a widespread impact. The first competition is underway and offers project support of up to $2 million. The program will be directed by a Learning Program committee, chaired by Dr Catherine Henderson, president of the Ontario College of Art and Design....

In other news, CANARIE is encouraging consortia to apply under competitions for the advanced end-to-end applications and the network technology streams of its ANAST funding program. The aim of the advanced network technology stream is to focus on key developments required to support next-generation Internet networks in the areas of transport and middleware services. The advanced end-to-end applications stream will support projects that work on technological and other developments needed to allow Internet distribution of audio, video and other high-performance applications. Consortia submissions that provide all the pieces necessary for building, implementing, evaluating and deploying systems on a national basis will be favoured....


Return to Research Briefs Index







 

Working Ventures teams with Univ of Waterloo to create fund Working Ventures Canadian Fund has invested in yet another Community Small Business Initiative Fund as part of the Ontario government's efforts to provide local sources of capital to early-stage high technology businesses (R$, February 4/98). Waterloo Ventures will receive an initial $5-million infusion from Working Ventures, in conjunction with the Univ of Waterloo, Wilfrid Laurier Univ and Conestoga College. The funds are part of the labour-sponsored venture capital firm's $15-million commitment to the program, which allows it to avoid paying a penalty for missing its provincial investment targets. The program also offers incentives for private investors, with a tax credit of 15% up to a maximum of $75,000. Initial investments up to $250,000 are eligible for follow-on investments up to 20% of the fund total....


Return to Research Briefs Index







 

Ontario dominates ranking of 50 fastest growing Canadian firms The phenomenal growth rate of Sierra Wireless Inc (SWI) has earned it the number one spot on Deloitte & Touche's 1999 Canadian Technology Fast 50 ranking. The Richmond BC-based developer of wireless technologies achieved a five-year growth rate of 7643.7%, outpacing number two-ranked TUCOWS Interactive Ltd of Toronto, which grew 6440% in the same period. The Greater Toronto Area accounted for six of the 10 fastest growing firms, while Waterloo contributed two. Montreal's Cognicase Inc grabbed the number three spot, while NTS Computer Systems Ltd of Vancouver ranked number seven. Ontario was home to an impressive 33 of the top 50 firms listed in the ranking. The ranking firms were asked to identify significant changes to the high sector over the next five years. The top changes were globalization of Canadian companies (29%), consolidation of the Canadian high tech industry (24%), and more web enabling technologies (21%)....


Return to Research Briefs Index







 

CME Telemetrix makes significant changes in corporate direction CME Telemetrix Inc has restructured its clinical development program, switched its chief scientific officer and signed a non-binding letter of intent with The Photonics Centre at Boston Univ. The changes are part of the Waterloo ON-based company's decision to focus on development of an advanced range non-invasive glucose monitoring product. CME decided to pursue development of the advanced instrument after its FDA advisory team concluded that intermediate approval strategies were not of value. The agreement with The Photonics Centre gives CME access to the US$80-million Boston facility, its staff and equipment. The new Boston-based scientific team will be led by Tom Scecina. He replaces Dr Tom Cadell, who will remain active in the company as a scientific advisor and remains a director of the corporation. Prior to joining CME, Scecina spent 21 years at Chiron Diagnostics, Medfield MA, formerly Ciba Corning Diagnostics....


Return to Research Briefs Index








  UBC targets high school students with unique science program The Univ of British Columbia has launched its Dean of Science Ambassadors program, which will see second- to fourth-year science students fan out into the community and area high schools and host student tours of the campus. The unique outreach program has attracted hundreds of volunteers from the 6,000 undergraduate science students enrolled in more than 50 honours and majors programs. The volunteers will also conduct research demonstrations and organize competitions, influencing how science education is perceived by the public at large....


Return to Research Briefs Index








  Allelix's merger with NPS ends bid for new corporate partner Allelix Biopharmaceuticals Inc, one of Canada's oldest biotechnology firms, is merging with NPS Pharmaceuticals Inc, Salt Lake City UT, in a complex share swap arrangement slated to close on or before January 31/00. The merger -- worth approximately US$40 million at current stock valuations -- will see NPS president/CEO Dr Hunter Jackson hold similar posts in the combined firm and oversee a 35% reduction in NPS staff and a reduction of expenses associated with its unpartnered programs. Allelix will experience no layoffs, but has already cut its staff in half over the past year. The new entity will maintain Canadian operations and operate in this country under the name NPS Allelix. In the US, it will be known as NPS Pharmaceuticals Inc. Once the share swap is complete, Allelix shareholders will own one third of the combined company. Graham Strachan, Allelix's president/CEO, announced his intention to step down 15 months ago once a search committee found a suitable replacement, but that course of action was never realized. Although Allelix has never placed a product on the market, it possesses many traits of a mature biotechnology company, with several key strategic alliances and flourishing subsidiaries. Earlier this year, the Canadian Medical Discoveries Foundation secured a $10-million stake in Allelix as its stock was near a one-year low, and placed its CEO, Dr Calvin Stiller, on the Allelix board....


Return to Research Briefs Index








  AxiaNet Media collaborates with Mayo Clinic on new web service Calgary-based Axia NetMedia Corpis working with the Mayo Clinic, Rochester MN to create the first module of an on-line website for neurology. Called a Global Centre for Knowledge in Neurology, the subscription-based service will offer comprehensive information and research on migraine headaches. The Mayo Clinic will provide the knowledge while Axia is furnish the necessary resource and project management expertise. The development phase of the project has already begun and it's hoped that, once complete, it will provide a forum for higher learning, peer interaction and expert content. There are about 200,000 neurologists worldwide....


Return to Research Briefs Index








  ImmGenics to develop monoclonal antibody with Genzyme Corp Vancouver-based ImmGenics Pharmaceuticals Inc has signed a co-development agreement with Genzyme Corp, Cambridge MA, to develop a high affinity biotherapeutic monoclonal antibody to an undisclosed antigen target. Financial terms of the deal were not disclosed, but the research project will utilize ImmGenic's SLAM technology to examine large numbers of immune cells using rapid throughput methods and select single cells for making antibodies with the desired traits. The agreement is the second major collaboration ImmGenics has entered in less than one year. Last November, the privately-held firm teamed with Corixa Corp, Seattle, to co-develop antibody-based therapeutic and diagnostic products against Corixa's cancer and infectious disease targets....


Return to Research Briefs Index









  Cangene R&D revenue jumps from Apotex project funding Greater development costs associated with projects funded by Apotex Inc has pushed up Cangene Corp's R&D revenues up 35% for FY99 ending July 31. Increased clinical trial activity and new projects conducted by the Apotex subsidiary registered $8.7 million in R&D revenue, which increased to $10.0 million when investment tax credits are included. For the same period, Cangene achieved net income of $15.4 million, up from $11.1 million in FY98....


Return to Research Briefs Index








  Labopharm terminates longstanding deal with unnamed drug firm Labopharm Inc has terminated its research program with an unnamed multinational drug firm, after the firm decided not to pursue the project, citing a change in corporate priorities. The project recently completed its second phase to modify the release profile of an existing drug using the Laval-based firm's Contramid controlled-release technology. Labopharm is putting its best face on the project's termination, noting that it has successfully developed a complex core technology which can be applied to a wide variety of drugs....


Return to Research Briefs Index



Return to TOP OF PAGE | RE$EARCH MONEY INDEX





 

PERSONALITIES


Dr Robert McMurtry begins his tenure as a visiting fellow at Health Canada next week to provide advice to the minister, DM and department on science and emerging health issues. The appointment earlier this year of McMurtry as the first GDW Cameron Visiting Fellow marks yet another indication that the department is proactively seeking advice from experts in the health and health care fields to enrich scientific and policy capacity. He will take part, on request, in departmental and international meetings as well as meetings with private sector groups and report directly to the DM. The term of the fellowship is one to two years and appointments are made under the federal government's interchange program. McMurtry is a specialist in orthopaedic surgery and is currently dean of the faculty of medicine and dentistry at the Univ of Western Ontario. He is a member of the Medical Research Council's governing council and sits on the interim governing council of the Canadian Institutes of Health Research. The visiting fellow concept was first hatched at the Finance department in the early 1990s under the direction of David Dodge, who moved to Health Canada last year as DM....

Paul Dufour has been appointed special assistant to Gilbert Normand, the new secretary of state for science research and development, serving as a liaison between Norman and the rest of the department on all science, technology and research issues. Dufour has held a number of senior advisory positions at Industry Canada pertaining to science and technology. Most recently, he was senior advisory to the Advisory Council on Science and Technology and was preparing to serve as secretariat to a new expert panel to examine Canada's role in international science and technology (R$, July 21/99)....

Dr Bill Rolston has been appointed VP information technology for Healthnet International Inc, an on-line retailer and provider of information on health and wellness. Prior to the appointment, Rolston was senior systems administrator for FreeRealTime.com, an online financial information service providing real time stock quotes....


RE$EARCH MONEY -- September 29, 1999
Return to TOP OF PAGE | RE$EARCH MONEY INDEX